Form 4 for ABT Abbott Laboratories
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-16 · accession 0001415889-23-010065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-20 | 2023-06-16 | ABT | Boudreau Philip P | VP | S - Sale | $106.00 | -8,000 | 15.4K | -34% | -$848.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-06-16 | S | D | 8,000 | $106.00 | 15,447 | D | — | — | (F1) The sale transaction was made pursuant to a Rule 10b5-1(c) plan adopted on February 24, 2023. |